Company Data
AbCellera Biologics Inc.
Ticker
ABCL
Current Price
$3.63 -2.16%
Market Cap
$1.1B
Price Target
Refer to Report
Volume
3.2M
52wk Range
$1.8906 - $6.515
Overview
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company’s AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.